Company Search:
Advanced Search
Sponsored Links
Beijing SL Pharmaceutical Co Ltd Company Snapshot
Beijing SL Pharmaceutical Co Ltd operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Beijing SL Pharmaceutical Co Ltd with three other companies in this sector in China: Boya Bio-pharmaceutical Group Co Ltd (2016 sales of 946.57 million Chinese Renmimbi [US$149.82 million] of which 56% was Blood Plasma), Tianjin Ringpu Bio-Technology Co Ltd (969.68 million Chinese Renmimbi [US$153.48 million] of which 63% was Veterinary Biological Products), and Changsheng Bio-technology Co Ltd (1.02 billion Chinese Renmimbi [US$161.11 million] of which 100% was Vaccine Sales).

Sales Analysis. Beijing SL Pharmaceutical Co Ltd reported sales of 1.01 billion Chinese Renmimbi (US$159.84 million) for the year ending December of 2016. This represents a decrease of 12.7% versus 2015, when the company's sales were 1.16 billion Chinese Renmimbi. Contributing to the drop in overall sales was the 32.7% decline in Other Operating, from 27.28 million Chinese Renmimbi to 18.37 million Chinese Renmimbi. There were also decreases in sales in Pharmaceuticals Industry (down 12.2% to 991.48 million Chinese Renmimbi) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Beijing SL Pharmaceutical Co Ltd
  Stock Performance Chart for Beijing SL Pharmaceutical Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 33.92
(Figures in Chinese Renmimbi)
1 Week 4.0%   13 Weeks 18.1%  
4 Weeks 3.8%   52 Weeks 23.0%  
Beijing SL Pharmaceutical Co Ltd Key Data:
  Ticker: 002038 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 1,009,847,414
(Year Ending Jan 2017).
Employees: 616
  Currency: Chinese Renmimbi Market Cap: 23,231,808,000
  Fiscal Yr Ends: December Shares Outstanding: 684,900,000
  Share Type: A Shares Closely Held Shares: 330,576,831
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.